Source: Annual Congress 2013 –COPD: markers and inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Sobradillo, A. Fuster, P. J. Marcos, A. Ortega, C. González, M. Aburto, J. L. Rodríguez, B. Alcázar, M. Calle, L. Puente (Vitoria, Palma de Mallorca, A coruña, M, Valencia, Galdakao, Madrid, Granada, Spain). Use of beta-blockers in COPD patients with heart-disease. BBEPOC study. Eur Respir J 2013; 42: Suppl. 57, 3296

Member's Comments

No comment yet.

Related content which might interest you: Clinical and inhaled drug profile of COPD patients with indication for beta-blockers who are on beta-blockers Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Evaluation of arrhythmia frequency in patients with COPD Source: International Congress 2015 – Different data in COPD Year: 2015 Cardiovascular status of patients with a severe form of COPD Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Prescribing patterns for UK patients commencing first maintenance therapy for COPD Source: International Congress 2014 – COPD markers Year: 2014 Comorbidities in patients with COPD and their impact on COPD course Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 Comorbidities in Swedish COPD and non-COPD patients: ARCTIC study Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016 Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Comorbidities in elderly smokers with COPD or CHF Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Carvedilol, bisoprolol, and metoprolol use in patients with coexistent heart failure and chronic obstructive pulmonary disease: A nationwide population-based study Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 High risk COPD patients cost less if treated according to GOLD 2011 recommendations Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Safety of tiotropium in patients with cardiac events in the TIOSPIR™ trial Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Top-10 comorbidities of symptomatic patients with moderate COPD in the clinical setting of the CRYSTAL study Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Comorbidities, gender-differences and COPD severity: The French Palomb cohort Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD treatment Year: 2013 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Comorbidities and COPD severity: The French Palomb cohort Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 COPDCoRi, an algorithm for predicting the risk of coronaropathy in COPD patients Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 Mortality and readmissions in patients with severe COPD. Validation of the CODEX index Source: International Congress 2015 – Best abstracts in COPD management Year: 2015